Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
28.41
-1.04 (-3.53%)
At close: Apr 2, 2026, 4:00 PM EDT
28.56
+0.15 (0.53%)
After-hours: Apr 2, 2026, 4:10 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.86 billion as of April 2, 2026. Its market cap has increased by 112.74% in one year.
Market Cap
1.86B
Enterprise Value
1.51B
1-Year Change
112.74%
Ranking
Category
Stock Price
$28.41
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.86B, an increase of 191.34%. That is a compound annual growth rate of 23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.86B | 2.92% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 2.05B |
| Mesoblast | 2.03B |
| Agios Pharmaceuticals | 2.00B |
| Galapagos NV | 1.98B |
| Viridian Therapeutics | 1.96B |
| Relay Therapeutics | 1.92B |
| Zymeworks | 1.91B |
| Soleno Therapeutics | 1.91B |